On the contrary, the combined treatment induced CDH1 expression at both the mRNA and protein levels, and reduced the EMT-related genes (Figure 3c, Figure S7b,c), as well as migration by scratch test (Figure S7d), thus suggesting that the EMT process is impaired in prostate cancer cells under estrogen plus hypoxia stress. The gene discussed is CDH1; the disease is prostate cancer.